Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and have made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continue to progress clinical and research programs in these diseases.
Vertex Pharmaceuticals is a global biotechnology leader focused on transforming the lives of people living with serious diseases. The company is known for its breakthroughs in cystic fibrosis and its expanding portfolio of innovative therapies across pain, sickle cell disease, and other high-impact conditions. Vertex partners with communities, clinicians, advocacy groups, and health systems to ensure that patients and families have access to education, support, and evidence based care.
Vertex works across the country to advance awareness, early detection, and equitable access for people affected by serious and complex conditions. Their community and patient engagement efforts include:
Vertex collaborates with local partners, barbershops, churches, neighborhood organizations, and health leaders to bring critical information and services directly to families. Their impact includes:
